Showing results (5201-5210 of 27,716) with videos related to

Sort By:
Pageof 2,772
Vaccine|September 23, 2022
Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care WorkersFotinie Ntziora, Evangelia Georgia Kostaki, Amalia Karapanou, et al.
Vaccine|September 23, 2022
A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, children, and adolescents (PNEU-PLAN)Natalie Banniettis, Jacek Wysocki, Leszek Szenborn, et al.
Vaccine|March 19, 2021
Quantifying movement patterns and vaccination status of high risk mobile populations in Pakistan and Afghanistan to inform poliovirus risk and vaccination strategyNatalia A Molodecky, Asma Usman, Asif Javaid, et al.
Vaccine|March 20, 2021
Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children aged less than five yearsMehmet Ceyhan, Eda Karadag-Oncel, Gulsen Hascelik, et al.
Vaccine|March 20, 2021
Hepatitis B birth dose vaccination patterns in the military health System, 2014-2018Jessica Fung Deerin, Rebecca Clifton, Angelo Elmi, et al.
Vaccine|March 20, 2021
Cost-effectiveness of pediatric norovirus vaccination in daycare settingsLauren N Steimle, Joshua Havumaki, Marisa C Eisenberg, et al.
Vaccine|January 26, 2021
Costs implications of pneumococcal vaccination of adults aged 30-60 with a recent diagnosis of diabetesDavid W Hutton, Jeffrey S McCullough, Lisa Prosser, et al.
Vaccine|January 26, 2021
A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in CameroonAdidja Amani, Collins A Tatang, Christian N Bayiha, et al.
Vaccine|January 26, 2021
Sex-differential non-specific effects of rabies vaccine in dogs: An extended analysis of a randomized controlled trial in a high-mortality populationDarryn L Knobel, Sintayehu M Arega, Anne Conan
Vaccine|January 19, 2021
Using data to improve outcomes of supplemental immunisation activities: 2017/2018 Nigeria measles vaccination campaignFred Ikechukwu Mogekwu, Joseph A Oteri, Peter Nsubuga, et al.
Pageof 2,772